BioCentury
ARTICLE | Clinical News

Viramune nevirapine: Phase IIIb data

July 27, 2009 7:00 AM UTC

Data from the open-label, international Phase IIIb ARTEN trial in 569 treatment-naïve HIV patients showed that once- or twice-daily Viramune plus Truvada emtricitabine/tenofovir met the primary endpo...